Transcriptional Establishment of Cell-Type Identity: Dynamics and Causal Mechanisms of T-Cell Lineage Commitment
Abstract
Precursor cell entry into the T-cell developmental pathway can be divided into two phases by the closure of T-lineage commitment. As cells decide against the last alternative options to the T-cell fate, they turn on the transcription factor Bcl11b and silence expression of a group of multipotent progenitor regulatory factors that include hematopoietic transcription factor PU.1. Functional perturbation tests show that Bcl11b is needed for commitment while PU.1 actively participates in keeping open access to alternative fates, until it is silenced; however, PU.1 and Bcl11b both contribute positively to T-cell development. Our recent work reviewed here sheds light on the transcriptional regulatory network that determines the timing and irreversibility of Bcl11b activation, the ways that Notch signaling from the thymic microenvironment restricts the action of PU.1 to prevent it from diverting cells to non-T fates, and the target genes that PU.1 still regulates under the influence of Notch signaling to contribute to T-cell generation. We argue that T-cell development depends on the sequential operation of two interlaced, but mutually antagonistic, gene regulatory networks, one initially supporting expansion before commitment and the other imposing a "terminal" differentiation process on committed cells.
Additional Information
© 2013 Cold Spring Harbor Laboratory Press. Published online October 17, 2013 in advance of the print volume. We thank our colleagues Michael Elowitz (Caltech), Eric Davidson (Caltech), Carsten Peterson (Lund University), Vijay Chickarmane (Caltech), and Erica Manesso (Lund University) for advice and stimulating theoretical discussions; Marei Dose and Fotini Gounari (University of Chicago) for sharing important ChIP-seq data sets; Irwin Bernstein (Fred Hutchinson Cancer Research Center) for advice and donating DL1-Fc; Stephen Nutt (Walter & Eliza Hall Institute), Mark Leid (Oregon State Health SciencesCenter), and Pentao Liu (Cambridge University) for valuable transgenic mouse strains; and Shirley Pease and the Caltech Genetically Modified Mouse Service for generation of new fluorescent reporter mouse strains, all of whom contributed to the experiments reviewed here. We are also indebted to Rochelle Diamond for outstanding laboratory management; Robert Butler, Ni Feng, Maria Lerica Gutierrez Quiloan, and Edward Hernandez for technical support; Diana Perez, Janice Grimm, and Josh Verceles for help with cell sorting; and Ingrid Soto for mouse care. Our work was made possible by support from National Institutes of Health (NIH) grants to E.V.R. (RC2 CA148278, R33 HL089123, R01 CA090233, R01 AI083514, and R01 AI095943) and to M.A.Y. (R01 AI064590), a Cancer Research Institute-Irvington Fellowship to H.Y.K., the Albert Billings Ruddock Professorship to E.V.R., the Al Sherman Foundation, and the Louis A. Garfinkle Memorial Laboratory Fund.Attached Files
Published - Rothenberg_2013p1.pdf
Files
Name | Size | Download all |
---|---|---|
md5:f480b5c2a4d475d695cdaa4db6ea48e9
|
740.1 kB | Preview Download |
Additional details
- PMCID
- PMC3990665
- Eprint ID
- 42100
- Resolver ID
- CaltechAUTHORS:20131028-142315690
- NIH
- RC2 CA148278
- NIH
- R33 HL089123
- NIH
- R01 CA090233
- NIH
- R01 AI083514
- NIH
- R01 AI095943
- NIH
- R01 AI064590
- Cancer Research Institute-Irvington Fellowship
- Albert Billings Ruddock Professorship
- Al Sherman Foundation
- Louis A. Garfinkle Memorial Laboratory Fund
- Created
-
2013-10-29Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field